Tilray Brands (TLRY) Enterprise Value (2017 - 2026)
Tilray Brands' (TLRY) quarterly Enterprise Value came in at -$254.1 million in Q2 2026, up 8.68% YoY from -$233.8 million in Q2 2025, and down 0.95% on a QoQ basis from -$251.7 million in Q1 2026.
Tilray Brands (TLRY) Enterprise Value (2017 - 2026) Analysis & Trends
Tilray Brands (TLRY) has 10 years of Enterprise Value data on file, last reported at -$254.1 million in Q2 2026.
- Quarterly Enterprise Value rose 8.68% year-over-year to -$254.1 million in Q2 2026, while the trailing twelve-month figure through May 2026 was -$254.1 million (up 8.68% YoY) and the FY2026 annual result came in at -$254.1 million, up 8.68% from the prior year.
- Enterprise Value retreated to -$254.1 million in Q2 2026, from -$251.7 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$234.8 million in Q4 2023 to a low of -$452.8 million in Q3 2022.
- A 5-year average of -$320.7 million and a median of -$278.3 million in 2025 frame the typical range for Enterprise Value.
- The widest YoY moves for Enterprise Value: up 44.19% in 2023, down 65.08% in 2023.
- Tracing TLRY's Enterprise Value over 5 years: stood at -$420.6 million in 2022, then soared by 44.19% to -$234.8 million in 2023, then declined by 15.67% to -$271.6 million in 2024, then slipped by 19.63% to -$324.9 million in 2025, then increased by 21.79% to -$254.1 million in 2026.
- The last three Enterprise Value figures came in at -$254.1 million (Q2 2026), -$251.7 million (Q1 2026), and -$324.9 million (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | -882.82 Mn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -3.65 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | -1.68 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -5.79 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | -2.66 Bn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -886.50 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | -389.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | -530.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | -164.00 Mn |
| 10 | Tilray Brands | 523.93 Mn | 289.30 Mn | 90.52 Mn | -254.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | -254.10 Mn |
| Feb 28, 2026 | -251.69 Mn |
| Nov 30, 2025 | -324.87 Mn |
| Aug 31, 2025 | -284.91 Mn |
| May 31, 2025 | -278.26 Mn |
| Nov 30, 2024 | -271.57 Mn |
| Aug 31, 2024 | -274.73 Mn |
| May 31, 2024 | -260.25 Mn |
| Feb 29, 2024 | -241.68 Mn |
| Nov 30, 2023 | -234.78 Mn |
| Aug 31, 2023 | -442.67 Mn |
| May 31, 2023 | -434.28 Mn |
| Feb 28, 2023 | -405.17 Mn |
| Nov 30, 2022 | -420.63 Mn |
| Aug 31, 2022 | -452.80 Mn |
| May 31, 2022 | -373.35 Mn |
| Feb 28, 2022 | -245.44 Mn |
| Nov 30, 2021 | -295.08 Mn |
| Aug 31, 2021 | -310.01 Mn |
| May 31, 2021 | -482.22 Mn |